medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 9, 2024
Abstract
Background
Recurrent
infections
of
the
nose,
sinuses,
and
ears
are
common
problems
for
people
with
primary
ciliary
dyskinesia
(PCD).
While
pulmonary
exacerbations
in
PCD
defined,
there
is
no
definition
Ear-Nose-Throat
(ENT)
exacerbations,
a
potential
outcome
research
clinical
trials.
Methods
We
set
up
an
expert
panel
24
ENT
specialists,
respiratory
physicians,
other
healthcare
professionals,
patients
to
develop
consensus
definitions
sinonasal
otologic
children
adults
settings.
reviewed
literature
used
modified
Delphi
approach
four
electronic
surveys.
Results
Both
based
on
combination
major
minor
criteria,
requiring
three
or
two
at
least
criteria
each.
Major
exacerbation
are:
1)
reported
acute
increase
nasal
discharge
change
colour;
2)
pain
sensitivity
sinus
regions;
3)
mucopurulent
examination.
Minor
include:
symptoms;
examination
signs;
doctoŕs
decision
treat;
improvement
after
14-days.
ear
sensitivity,
discharge,
examination,
4)
signs
otitis
media
otoscopy.
hearing
problems;
complication;
treat.
Conclusion
These
might
offer
useful
measure
different
They
should
be
validated
future
studies
trials
together
outcomes,
assess
their
usability.
Magnetic Resonance in Chemistry,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 2, 2023
Abstract
Biofilm
formation
protects
bacteria
from
antibiotic
treatment
and
host
immune
responses,
making
biofilm
infections
difficult
to
treat.
Within
biofilms,
bacterial
cells
are
entangled
in
a
self‐produced
extracellular
matrix
that
typically
includes
exopolysaccharides.
Molecular‐level
descriptions
of
components,
especially
exopolysaccharides,
have
been
challenging
attain
due
their
complex
nature
lack
solubility
crystallinity.
Solid‐state
nuclear
magnetic
resonance
(NMR)
has
emerged
as
key
tool
determine
the
structure
exopolysaccharides
without
degradative
sample
preparation.
In
this
review,
we
discuss
challenges
studying
opportunities
develop
solid‐state
NMR
approaches
study
these
generally
intractable
materials.
We
specifically
highlight
investigations
exopolysaccharide
called
Pel
made
by
opportunistic
pathogen,
Pseudomonas
aeruginosa
.
provide
roadmap
for
determining
future
such
systems
using
NMR.
The
strategies
discussed
elucidating
should
be
broadly
applicable
structures
other
glycans.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 25, 2024
Pseudomonas
aeruginosa
is
an
opportunistic
bacterial
pathogen
responsible
for
a
large
percentage
of
airway
infections
that
cause
morbidity
and
mortality
in
immunocompromised
patients,
especially
those
with
cystic
fibrosis
(CF).
One
important
P.
virulence
factor
type
III
secretion
system
(T3SS)
translocates
effectors
into
host
cells.
ExoS
T3SS
effector
ADP
ribosyltransferase
(ADPRT)
activity.
The
ADPRT
activity
promotes
by
inhibiting
phagocytosis
limiting
the
oxidative
burst
neutrophils.
also
flagellin,
which
can
activate
NLRC4
inflammasome,
resulting
in:
1)
gasdermin-D
(GSDMD)
pores,
release
IL-1β
pyroptosis;
2)
histone
3
citrullination
(CitH3)
decondensation
expansion
nuclear
DNA
cytosol.
However,
recent
studies
laboratory
strain
PAO1
indicate
inhibits
activation
inflammasome
Here,
ExoS+
CF
clinical
isolate
hyperactive
was
identified.
Variants
mutant
or
were
used
to
infect
neutrophils
from
C57BL/6
mice
engineered
have
genotype
defect
assembly.
Responses
assembly
assayed,
results
found
be
similar
had
enhanced
resistance
neutrophil
killing,
like
previously
identified
hypervirulent
isolates.
regulated
responses
but
promoted
CitH3
plasma
membrane
rupture
(PMR).
Glycine
supplementation
inhibited
PMR
caused
mutant,
suggesting
ninjurin-1
required
this
process.
These
identify
as
pathogenic
OTO Open,
Journal Year:
2024,
Volume and Issue:
8(1)
Published: Jan. 1, 2024
Abstract
Objective
Sinus
disease
is
prevalent
in
persons
with
cystic
fibrosis
(PwCF)
and
may
be
a
reservoir
of
airway
infection
postlung
transplant
(pTx)
patients.
The
microbial
composition
sinuses
its
associations
chronic
rhinosinusitis
(CRS)
relatively
unexplored.
We
aimed
to
examine
the
sinus
lower
microbiome
their
CRS
PwCF
pTxPwCF.
Study
Design
Prospective
single‐centre
study.
Setting
A
total
31
sex
age
(±2
years)
matched
Methods
Demographic
clinical
data
along
swabs
sputum
were
collected.
was
assessed
using
Sinonasal
Outcome
Test‐22
(SNOT‐22)
(patient
reported
outcome)
Lund‐McKay
(computed
tomography
sinus)
scores.
Samples
underwent
MiSeq
Illumina
sequencing
universal
16S
ribosomal
RNA
gene.
Results
(15
pTxPwCF)
included.
Aggregate
airways
dominated
by
Pseudomonas
(46%),
Haemophilus
(14%),
Staphylococcus
(11%),
Streptococcus
(10%),
Fusobacterium
(6%).
α‐diversity
significantly
post‐Tx
samples
across
both
(
P
=
.005).
β‐diversity
different
between
.004),
but
not
.75)
status.
While
there
trend
higher
associated
SNOT‐22
score
at
time
first
visit,
this
did
reach
significance
.05).
Conclusion
microbiomes
differed
pTxPwCF,
organisms
remained
consistent.
Elucidating
relationship
status
better
understand
when
intervene
accordingly
needed
optimize
management
PwCF.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 9, 2024
Abstract
Background
Recurrent
infections
of
the
nose,
sinuses,
and
ears
are
common
problems
for
people
with
primary
ciliary
dyskinesia
(PCD).
While
pulmonary
exacerbations
in
PCD
defined,
there
is
no
definition
Ear-Nose-Throat
(ENT)
exacerbations,
a
potential
outcome
research
clinical
trials.
Methods
We
set
up
an
expert
panel
24
ENT
specialists,
respiratory
physicians,
other
healthcare
professionals,
patients
to
develop
consensus
definitions
sinonasal
otologic
children
adults
settings.
reviewed
literature
used
modified
Delphi
approach
four
electronic
surveys.
Results
Both
based
on
combination
major
minor
criteria,
requiring
three
or
two
at
least
criteria
each.
Major
exacerbation
are:
1)
reported
acute
increase
nasal
discharge
change
colour;
2)
pain
sensitivity
sinus
regions;
3)
mucopurulent
examination.
Minor
include:
symptoms;
examination
signs;
doctoŕs
decision
treat;
improvement
after
14-days.
ear
sensitivity,
discharge,
examination,
4)
signs
otitis
media
otoscopy.
hearing
problems;
complication;
treat.
Conclusion
These
might
offer
useful
measure
different
They
should
be
validated
future
studies
trials
together
outcomes,
assess
their
usability.